The San Antonio Cancer Institute Flow Cytometry Core Facility is located within the University of Texas Health Science Center at San Antonio (UTHSCSA) Institutional Flow Cytometry Facility. The core includes a state-of-the-art rapid cell sorter (FACSstar Plus; 10,000 events/sec) and a new FACScalibur instrument for 3-4 color analysis. The facility is equipped with two workstations and two advanced printers (Tektronix). The Director of the combined facilities is Dr. Yair Gazitt (Medicine/Hematology, UTHSCSA), who has used flow cytometry for analysis and sorting since 1977 and has been the Director of the institutional Flow Cytometry Core Facility for the past five years. The core supports cell sorting and cloning of specific subpopulations of lymphocytes, various tumor cells, osteoclasts, osteoblasts, stem cells and kidney cells. This includes mouse models and human studies. Basic services offered to the San Antonio Cancer Institute consist of immunophenotyping (including leukemia, lymphoma breast cancer cells), DNA content and cell cycle analysis (including apoptosis analysis), cell sorting, multiparameter analysis (3-3 color), Ca++ fluxes, measurement of MDR-1 function and apoptosis. The facility has been instrumental in the success of several key established Cancer Center investigators and work is ongoing to develop new techniques in response to needs identified by SACI members. Protocols currently under development include sorting by DNA content and multiparameter cytokine quantitation using fluorescent microspheres (Becton Dickinson), a fluorescence based """"""""ELISA"""""""" assay.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ctrc Research Foundation
San Antonio
United States
Zip Code
Donegan, Jennifer J; Boley, Angela M; Lodge, Daniel J (2018) Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism. Neuropsychopharmacology 43:1789-1798
Segovia, Jesus A; Chang, Te-Hung; Winter, Vicki T et al. (2018) NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection. Infect Immun 86:
Cepeda, Sergio; Cantu, Carolina; Orozco, Stephanie et al. (2018) Age-Associated Decline in Thymic B Cell Expression of Aire and Aire-Dependent Self-Antigens. Cell Rep 22:1276-1287
Vaidya, Anand; Flores, Shahida K; Cheng, Zi-Ming et al. (2018) EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease. N Engl J Med 378:1259-1261
Ramasamy, Kumaraguruparan; Balasubramanian, Sowmya; Manickam, Krishnan et al. (2018) Mycoplasma pneumoniae Community-Acquired Respiratory Distress Syndrome Toxin Uses a Novel KELED Sequence for Retrograde Transport and Subsequent Cytotoxicity. MBio 9:
Snead, Wilton T; Zeno, Wade F; Kago, Grace et al. (2018) BAR scaffolds drive membrane fission by crowding disordered domains. J Cell Biol :
Cui, Xiaodong; Zhang, Lin; Meng, Jia et al. (2018) MeTDiff: A Novel Differential RNA Methylation Analysis for MeRIP-Seq Data. IEEE/ACM Trans Comput Biol Bioinform 15:526-534
Hermann, Brian P; Cheng, Keren; Singh, Anukriti et al. (2018) The Mammalian Spermatogenesis Single-Cell Transcriptome, from Spermatogonial Stem Cells to Spermatids. Cell Rep 25:1650-1667.e8
Chalela, Patricia; Muñoz, Edgar; Gallion, Kipling J et al. (2018) Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study. Transl Behav Med 8:439-449
Chalela, P; Munoz, E; Inupakutika, D et al. (2018) Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun 12:109-115

Showing the most recent 10 out of 989 publications